Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply
Alimentary Pharmacology & Therapeutics · 18.11.2026
DOI: 10.1111/apt.71109 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 18.11.2026. Verfasst von Juma A Mohamedi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Die Arbeit nennt 7 Literaturangaben. Gefördert von: VLIRUOS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
- Department of Pharmaceutics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
- Department of Gastroenterology, HUB Hôpital Erasme, Brussels, Belgium.
ORCID-Profile: Juma A Mohamedi, Claire Liefferinckx, Erwin Dreesen
Förderung
- VLIRUOS
Zitieren
APA
Mohamedi, J. A., Liefferinckx, C., & Dreesen, E. (2026). Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71109
Vancouver
Mohamedi JA, Liefferinckx C, Dreesen E. Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71109
BibTeX
@article{Mohamedi2026,
author = {Mohamedi, Juma A and Liefferinckx, Claire and Dreesen, Erwin},
title = {Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71109}
}
EUVIMED